Capture Pharma Bridge & # 39; Martin Shkreli sues the case and claimed he was deceived

Pharmaceutical CEO Martin Shkreli, currently in prison, initiated a lawsuit on Friday against three leaders at his former drugstore Retrophin.

The so-called "pharma bridge" said Retrophin's chairman, CEO and Advocate General illegally expelled him from the company and stole $ 30 million. He claims that these people benefited from their removal and were driven by "ego, jealousy, and greed."


The case was filed in the federal court in Manhattan.

Shkreli was sentenced to seven years in prison after being found guilty of security fraud for allegedly operating his business as a Ponzi scheme. While losing millions of investors dollars on bad trades, he is said to have paid them back with the profits he made from his drugstore Retrophin.

Shkreli is also known for price equalization. In 201[ads1]5, he infamously increased the price of his HIV drug, Daraprim, by 5000 percent – to $ 750 per pill from $ 13.50 – a decision he defended at that time.


A judge found Shkreli responsible for $ 6.4 million as investors invested in their funds as a result of fraud and $ 4 million to attempt to dissolve Retrophin's share price by attempting to prevent investors from selling their shares.

The Wall Street Journal reported it, while behind bars, Shkreli drove pharmaceutical firm Phoenixus AG using an alley cell phone. Since then he has been in isolation.

Source link

Back to top button